Spectrum of CNS disease caused by rapidly growing mycobacteria. (Q37172588)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Spectrum of CNS disease caused by rapidly growing mycobacteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Carlos Franco-Paredes

series ordinal

4

object named as

Carlos Franco-Paredes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Naasha J Talati

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Krutika Kuppalli

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

390-398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

Nontuberculous mycobacterial meningitis: report of two cases and review

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

An outbreak of mycobacterial furunculosis associated with footbaths at a nail salon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Broviac catheter-related infection due to Mycobacterium fortuitum in a patient with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Mycobacterium chelonae peritonitis associated with continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty: clinical and epidemiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Diversity and sources of rapidly growing mycobacteria associated with infections following cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Pulmonary disease caused by rapidly growing mycobacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Disseminated Mycobacterium abscessus infection manifesting as fever of unknown origin and intra-abdominal lymphadenitis: case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Disseminated infection with rapidly growing mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Mycobacterium fortuitum complex endocarditis-case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Fastidious Mycobacteria Grown from Porcine Prosthetic-Heart-Valve Cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Mycobacterium abscessus endophthalmitis: treatment dilemma and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Nontuberculous (atypical) mycobacterial keratitis after LASIK: current status and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Mycobacterium abscessus keratitis after LASIK with IntraLase femtosecond laser.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Bacteriology of brain abscess - observations on 50 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Nontuberculous mycobacterial infection of the central nervous system in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Mycobacterium fortuitum—A Human Pathogen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Clinical Usefulness of Amikacin and Doxycycline in the Treatment of Infection Due to Mycobacterium fortuitum and Mycobacterium chelonei

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Fatal Mycobacterium fortuitum meningitis in a patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Mycobacterium fortuitum infection of ventriculoperitoneal shunt.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Mycobacterium fortuitum meningitis associated with an epidural catheter: case report and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Neurologic manifestations of disseminated infection with Mycobacterium abscessus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Multiple cerebral abscesses as a complication of Mycobacterium fortuitum infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Report of two fatal cases of Mycobacterium mucogenicum central nervous system infection in immunocompetent patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Cerebrospinal fluid penetration of amikacin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Clarithromycin clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Biofilm formation by the rapidly growing mycobacterial species Mycobacterium fortuitum.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Dexamethasone in adults with bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Activities of linezolid against rapidly growing mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Partial interferon-gamma receptor deficiency and non-tuberculous mycobacterial lung disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Regional deposition of aerosolized interferon-gamma in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

Treatment of refractory disseminated Mycobacterium abscessus infection with interferon gamma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970127-0

7 January 2021

10.1016/S1473-3099(08)70127-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18501854%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference